PL2692345T3 - Kompozycja farmaceutyczna do zapobiegania lub leczenia zwyrodnienia plamki żółtej - Google Patents
Kompozycja farmaceutyczna do zapobiegania lub leczenia zwyrodnienia plamki żółtejInfo
- Publication number
- PL2692345T3 PL2692345T3 PL12764888T PL12764888T PL2692345T3 PL 2692345 T3 PL2692345 T3 PL 2692345T3 PL 12764888 T PL12764888 T PL 12764888T PL 12764888 T PL12764888 T PL 12764888T PL 2692345 T3 PL2692345 T3 PL 2692345T3
- Authority
- PL
- Poland
- Prior art keywords
- preventing
- pharmaceutical composition
- macular degeneration
- treating macular
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20110028946 | 2011-03-30 | ||
| EP12764888.9A EP2692345B1 (en) | 2011-03-30 | 2012-03-29 | Pharmaceutical composition for preventing or treating macular degeneration |
| PCT/KR2012/002310 WO2012134187A2 (ko) | 2011-03-30 | 2012-03-29 | 황반변성 예방 또는 치료용 약학 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2692345T3 true PL2692345T3 (pl) | 2018-03-30 |
Family
ID=46932137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12764888T PL2692345T3 (pl) | 2011-03-30 | 2012-03-29 | Kompozycja farmaceutyczna do zapobiegania lub leczenia zwyrodnienia plamki żółtej |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20140018402A1 (pl) |
| EP (1) | EP2692345B1 (pl) |
| JP (1) | JP6099209B2 (pl) |
| KR (1) | KR101891078B1 (pl) |
| CN (2) | CN103501782A (pl) |
| AU (1) | AU2012237066B2 (pl) |
| BR (1) | BR112013022124A2 (pl) |
| CA (1) | CA2831025C (pl) |
| DK (1) | DK2692345T3 (pl) |
| ES (1) | ES2643377T3 (pl) |
| HU (1) | HUE036473T2 (pl) |
| PL (1) | PL2692345T3 (pl) |
| PT (1) | PT2692345T (pl) |
| RU (1) | RU2576380C2 (pl) |
| WO (1) | WO2012134187A2 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140018402A1 (en) * | 2011-03-30 | 2014-01-16 | Catholic University Industry Academic Cooperation Foundation | Pharmaceutical composition for preventing or treating macular degeneration |
| KR102484846B1 (ko) * | 2015-11-27 | 2023-01-05 | 한림제약(주) | 벤조피란 유도체의 정제방법, 이의 결정형 및 상기 결정형의 제조방법 |
| KR102478553B1 (ko) * | 2018-02-28 | 2022-12-16 | 한림제약(주) | 벤조피란 유도체 또는 이의 약학적으로 허용가능한 염을 포함하는 용액 형태의 점안제 |
| KR102282535B1 (ko) * | 2019-11-21 | 2021-07-27 | 한국화학연구원 | 방사선 조사에 의한 조직 또는 세포 손상의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5837702A (en) * | 1993-10-07 | 1998-11-17 | Bristol-Myers Squibb Co. | 4-arylamino-benzopyran and related compounds |
| IL149177A0 (en) * | 1999-11-05 | 2002-11-10 | Sod Conseils Rech Applic | Novel heterocyclic compounds and their use as medicines |
| CN100503602C (zh) * | 2002-04-10 | 2009-06-24 | 东部韩农化学株式会社 | 用包括四唑的仲胺取代的苯并吡喃衍生物、其制备方法以及含有它们的药物组合物 |
| KR100492252B1 (ko) * | 2002-08-09 | 2005-05-30 | 한국화학연구원 | 이미다졸을 포함하는 이차아민으로 치환된 벤조피란유도체 및 그의 제조방법 |
| WO2006000607A1 (es) * | 2004-06-23 | 2006-01-05 | Neurotec Pharma, S.L. | Uso de activadores de los canales de katp (kco), en particular el diazóxido, en el tratamiento de la inflamación crónica de snc asociada a algunas efermedades |
| WO2007064752A2 (en) * | 2005-11-29 | 2007-06-07 | Smithkline Beecham Corporation | Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema |
| US20070167526A1 (en) * | 2005-12-19 | 2007-07-19 | Xiaoming Zhang | Topical mecamylamine formulations for ocular administration and uses thereof |
| CN101687786B (zh) * | 2007-02-22 | 2013-05-22 | 奥特拉控股公司 | 羟胺化合物及其用法 |
| ES2370751T3 (es) * | 2007-05-25 | 2011-12-22 | Santen Pharmaceutical Co., Ltd | Agente profiláctico o terapéutico para la degeneración macular asociada a la edad. |
| CN102006872A (zh) * | 2008-02-19 | 2011-04-06 | 马韦尔生命科学有限公司 | 含有吡啶酚衍生物的眼科制剂 |
| TW201105363A (en) * | 2009-07-14 | 2011-02-16 | Univ Yamagata | Eye drop for macular edema treatment |
| US20140018402A1 (en) * | 2011-03-30 | 2014-01-16 | Catholic University Industry Academic Cooperation Foundation | Pharmaceutical composition for preventing or treating macular degeneration |
-
2011
- 2011-03-29 US US14/008,112 patent/US20140018402A1/en not_active Abandoned
-
2012
- 2012-03-29 WO PCT/KR2012/002310 patent/WO2012134187A2/ko active Application Filing
- 2012-03-29 AU AU2012237066A patent/AU2012237066B2/en active Active
- 2012-03-29 EP EP12764888.9A patent/EP2692345B1/en active Active
- 2012-03-29 KR KR1020120032161A patent/KR101891078B1/ko active IP Right Grant
- 2012-03-29 PL PL12764888T patent/PL2692345T3/pl unknown
- 2012-03-29 CA CA2831025A patent/CA2831025C/en active Active
- 2012-03-29 PT PT127648889T patent/PT2692345T/pt unknown
- 2012-03-29 HU HUE12764888A patent/HUE036473T2/hu unknown
- 2012-03-29 ES ES12764888.9T patent/ES2643377T3/es active Active
- 2012-03-29 JP JP2014502468A patent/JP6099209B2/ja active Active
- 2012-03-29 RU RU2013147449/04A patent/RU2576380C2/ru active
- 2012-03-29 CN CN201280014218.1A patent/CN103501782A/zh active Pending
- 2012-03-29 BR BR112013022124A patent/BR112013022124A2/pt not_active Application Discontinuation
- 2012-03-29 DK DK12764888.9T patent/DK2692345T3/en active
- 2012-03-29 CN CN201510780754.8A patent/CN105380946A/zh active Pending
-
2018
- 2018-03-30 US US15/941,856 patent/US10485786B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PT2692345T (pt) | 2017-10-19 |
| WO2012134187A2 (ko) | 2012-10-04 |
| CA2831025A1 (en) | 2012-10-04 |
| US20140018402A1 (en) | 2014-01-16 |
| BR112013022124A2 (pt) | 2019-09-10 |
| ES2643377T3 (es) | 2017-11-22 |
| HUE036473T2 (hu) | 2018-07-30 |
| EP2692345B1 (en) | 2017-07-19 |
| EP2692345A2 (en) | 2014-02-05 |
| AU2012237066B2 (en) | 2016-08-25 |
| DK2692345T3 (en) | 2017-10-30 |
| RU2576380C2 (ru) | 2016-03-10 |
| CN105380946A (zh) | 2016-03-09 |
| JP2014509643A (ja) | 2014-04-21 |
| KR101891078B1 (ko) | 2018-08-23 |
| RU2013147449A (ru) | 2015-05-10 |
| CN103501782A (zh) | 2014-01-08 |
| JP6099209B2 (ja) | 2017-03-22 |
| US20180221343A1 (en) | 2018-08-09 |
| KR20120112162A (ko) | 2012-10-11 |
| WO2012134187A3 (ko) | 2012-12-06 |
| EP2692345A4 (en) | 2014-08-27 |
| AU2012237066A1 (en) | 2013-09-26 |
| US10485786B2 (en) | 2019-11-26 |
| CA2831025C (en) | 2018-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2672966T3 (pl) | Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania | |
| AP3864A (en) | Pharmaceutical composition | |
| PT2729151T (pt) | Composição farmacêutica, métodos de tratamento e suas utilizações | |
| GB201118232D0 (en) | Pharmaceutical composition | |
| HK1202248A1 (en) | Compositions and methods for treating neurodegenerative disease | |
| EP2558103A4 (en) | PHARMACEUTICAL COMPOSITION FOR TREATING A MACULAR DERM | |
| EP2709614A4 (en) | PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF CANCER | |
| HK1202246A1 (en) | Compositions and methods for treating neurodegenerative disease | |
| HK1189158A1 (en) | Pharmaceutical composition | |
| EP2668186A4 (en) | PHARMACEUTICAL COMPOSITION WITH PYRIDIDE DERIVATIVES | |
| IL236112B (en) | Pharmaceutical preparations containing verbena for the treatment or prevention of neurodegenerative diseases | |
| EP2774917A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES | |
| HK1187336A1 (en) | Pharmaceutical composition comprising pyridone derivatives | |
| SG11201400976WA (en) | Methods and pharmaceutical compositions for treating cancer | |
| PL2692345T3 (pl) | Kompozycja farmaceutyczna do zapobiegania lub leczenia zwyrodnienia plamki żółtej | |
| EP2727593A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL | |
| EP2926817A4 (en) | STABLE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OSTEOPOROSIS | |
| EP2711010A4 (en) | PHARMACEUTICAL COMPOSITION | |
| HUP1100444A2 (en) | Pharmaceutical composition | |
| EP2826488A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF ARTERIOSCLEROSIS | |
| PL2663318T3 (pl) | Kompozycja farmaceutyczna do leczenia raka | |
| SI2497774T1 (sl) | Derivati dihidrooksazolobenzodiazepinona, postopki za njihovo pripravo in farmacevtski sestavki, ki te spojine vsebujejo | |
| EP2730288A4 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING FIBROSIS | |
| EP2785343A4 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HYPERLIPIDEMIA | |
| EP2712621A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR TREATING HYPERPROLIFERATIVE DISEASES |